-
CX-5461: RNA Polymerase I Inhibitor Workflow
2026-08-16
CX-5461 gives cancer researchers a focused way to interrogate Pol I-driven rRNA synthesis, ribosome biogenesis stress, DNA damage, senescence, and autophagy. This workflow connects concentration-response testing with mechanistic assays and cisplatin-sensitization studies in solid-tumor models.
-
WY-14643 (Pirinixic Acid): PPARα Research Guide
2026-08-15
WY-14643, also called Pirinixic Acid, is a reported selective PPARα agonist used to investigate lipid metabolism regulation, inflammation, and metabolic disorder research. Product and animal-model evidence support its use as a mechanistic benchmark, while dose, route, solubility, and model-specific limitations require careful interpretation.
-
Boc-D-FMK Workflows for Apoptosis Research
2026-08-15
Boc-D-FMK is a cell-permeable pan-caspase inhibitor for separating caspase-dependent cell death from inflammatory and drug-metabolism effects. This guide translates its reported use in apoptosis, renal endothelial inflammation, and hepatocyte models into practical workflows, controls, and troubleshooting strategies.
-
Tacrine Hydrochloride Hydrate: Assay Logic
2026-08-14
Tacrine hydrochloride hydrate is more than a legacy cholinesterase inhibitor: it is a powerful reference probe for separating target engagement, cholinergic signaling, and neuroprotection in Alzheimer’s disease research. This article presents an assay-interpretation framework that connects biochemical measurements with cell-based neurodegenerative disease models.
-
FPH1 (BRD-6125) Hepatocyte Expansion Guide
2026-08-14
FPH1 (BRD-6125) supports functional expansion workflows that measure more than cell number, linking hepatocyte proliferation with albumin, CYP3A4, and AFP readouts. This guide covers primary human hepatocyte culture, iPSC-derived hepatocyte assays, compound handling, and practical troubleshooting.
-
Cepharanthine and Endometriosis: Organoid Evidence
2026-08-13
The 2026 reference study evaluates Cepharanthine across endometriotic stromal cells, patient-derived endometrial organoids, and a murine peritoneal model. Its central contribution is a translational evidence chain linking reduced proliferation to DNA damage, impaired repair, cell-cycle arrest, and mitochondrial apoptosis, while also defining the limits of preclinical interpretation.
-
SU5416: VEGFR2 Workflows for Angiogenesis
2026-08-13
SU5416 (Semaxanib) provides a practical VEGFR2-focused tool for separating VEGF-driven endothelial responses from broader effects on proliferation and survival. This guide connects angiogenesis assays with the AURKB-centered pulmonary hypertension study while emphasizing dose design, controls, formulation, and interpretation limits.
-
Bestatin as a Chemical Probe of Jasmonate Signaling
2026-08-12
The reference study established bestatin as a selective chemical perturbation of jasmonate-associated responses in Arabidopsis and tomato, while showing that its activity depends on COI1 but not strictly on jasmonate biosynthesis. By combining transcriptomics, developmental phenotyping, and bestatin-resistant mutants, the authors developed a chemical-genetic framework for identifying previously unrecognized regulators of jasmonate signaling.
-
BKT140 (BL-8040) CXCR4 Research Workflows
2026-08-12
BKT140, also called BL-8040 and TF 14016, supports practical studies of CXCR4-driven migration, tumor–microenvironment signaling, apoptosis, and stem cell mobilization. This guide translates receptor biology and recent theranostic insights into assay-ready workflows, formulation guidance, and troubleshooting strategies.
-
BCECF Workflows for Extracellular pH Research
2026-08-11
BCECF converts extracellular acid-base changes into a quantitative ratiometric readout for ion transport, metabolism, and immune-microenvironment studies. This workflow shows how to apply the probe to neuropathic pain research while separating validated pathway evidence from testable pH hypotheses.
-
Firefly Luciferase mRNA as an Assay Calibrator
2026-08-10
Firefly Luciferase mRNA (ARCA, 5-moUTP) is more than a luminescent reporter: it can help separate transcript delivery, translation, and assay chemistry. This article connects its molecular design to delivery-platform evidence and more defensible gene expression, viability, and imaging decisions.
-
Hypoxia and Immunometabolism in the Tumor Microenvironment
2026-08-09
This review frames tumor hypoxia and immunometabolism as a reinforcing feedback system rather than as separate features of cancer biology. Its main practical contribution is a mechanistic map linking oxygen limitation, nutrient competition, immune-cell dysfunction, and therapeutic resistance, while highlighting experimental strategies for connecting metabolic and redox measurements to tumor–immune interactions.
-
Galectin-1, FIP200, and Hepatic Steatosis
2026-08-08
The reference study identifies a Galectin-1–FIP200 interaction as an upstream mechanism that suppresses autophagy and promotes hepatic steatosis, dyslipidemia, and insulin resistance. Its combination of mouse models, proteomic analysis, interaction mapping, and mutational validation provides a mechanistic framework for studying autophagy failure in NAFLD.
-
Reactive Oxygen Species Assay Kit for Radiotherapy
2026-08-07
A translational perspective on using DCFH-DA-based ROS measurement to connect FLASH-RT radiosensitization, oxidative damage, apoptosis, and immune remodeling with decision-grade experimental workflows.
-
Tacalcitol Monohydrate Enhances 5-FU Sensitivity in CRC Cell
2026-08-07
This article reviews a study demonstrating that tacalcitol, a synthetic analog of vitamin D3, significantly increases the sensitivity of colorectal cancer (CRC) cells to 5-fluorouracil (5-FU) by downregulating thymidylate synthase via vitamin D receptor (VDR)-dependent pathways. The findings provide mechanistic insight into how vitamin D analogs can be leveraged to improve standard chemotherapy outcomes in CRC models.
455 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page